Hwang YY - Search Results

1

Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM.

Tang HKK, Fung CY, Hwang YY, Lee H, Lau G, Yip SF, Kho B, Lau CK, Leung KH, Au E, Tse E, Sim J, Kwong YL, Chim CS. Tang HKK, et al. Among authors: hwang yy. Bone Marrow Transplant. 2024 May;59(5):660-669. doi: 10.1038/s41409-024-02227-0. Epub 2024 Feb 21. Bone Marrow Transplant. 2024. PMID: 38383715 Free PMC article.

2

Protein-losing enteropathy due to T-cell large granular lymphocyte leukemia.

Hwang YY, Leung AY, Ng IO, Chan GS, Chan KW, Tse E, Kwong YL. Hwang YY, et al. J Clin Oncol. 2009 Apr 20;27(12):2097-8. doi: 10.1200/JCO.2008.20.4768. Epub 2009 Mar 23. J Clin Oncol. 2009. PMID: 19307498 No abstract available.

3

Restoration of chemosensitivity by bortezomib: implications for refractory myeloma.

Chim CS, Hwang YY, Pang C, Shek TW. Chim CS, et al. Among authors: hwang yy. Nat Rev Clin Oncol. 2009 Apr;6(4):237-40. doi: 10.1038/nrclinonc.2009.15. Nat Rev Clin Oncol. 2009. PMID: 19333230

4

Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.

Hwang YY, Tse E, So JC, Wan TS, Kwong YL. Hwang YY, et al. Am J Hematol. 2009 May;84(5):302-5. doi: 10.1002/ajh.21383. Am J Hematol. 2009. PMID: 19338042 Free article. No abstract available.

5

Primary immune thrombocytopenia responding to antithyroid treatment in a patient with Graves' disease.

Gill H, Hwang YY, Tse E. Gill H, et al. Among authors: hwang yy. Ann Hematol. 2011 Feb;90(2):223-4. doi: 10.1007/s00277-010-0983-4. Epub 2010 May 14. Ann Hematol. 2011. PMID: 20467745 Free PMC article. No abstract available.

6

Atypical Burkitt's lymphoma transforming from follicular lymphoma.

Hwang YY, Loong F, Chung LP, Chim CS. Hwang YY, et al. Diagn Pathol. 2011 Jul 8;6:63. doi: 10.1186/1746-1596-6-63. Diagn Pathol. 2011. PMID: 21736761 Free PMC article. Review.

7

Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.

Chan TS, Hwang YY, Gill H, Au WY, Leung AY, Tse E, Chim CS, Loong F, Kwong YL. Chan TS, et al. Among authors: hwang yy. Clin Transplant. 2012 Sep-Oct;26(5):679-83. doi: 10.1111/j.1399-0012.2011.01593.x. Epub 2012 Feb 10. Clin Transplant. 2012. PMID: 22324300

8

Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning second transplantation from the original donor.

Leung AY, Tse E, Hwang YY, Chan TS, Gill H, Chim CS, Lie AK, Kwong YL. Leung AY, et al. Among authors: hwang yy. Am J Hematol. 2013 Jun;88(6):485-91. doi: 10.1002/ajh.23439. Epub 2013 May 2. Am J Hematol. 2013. PMID: 23512868 Free article.

9

Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients.

Chan TS, Gill H, Hwang YY, Sim J, Tse AC, Loong F, Khong PL, Tse E, Leung AY, Chim CS, Lie AK, Kwong YL. Chan TS, et al. Among authors: hwang yy. Ann Hematol. 2014 Mar;93(3):493-8. doi: 10.1007/s00277-013-1882-2. Epub 2013 Aug 15. Ann Hematol. 2014. PMID: 23949318

10

Valganciclovir suppressed Epstein Barr virus reactivation during immunosuppression with alemtuzumab.

Gill H, Hwang YY, Chan TS, Pang AW, Leung AY, Tse E, Kwong YL. Gill H, et al. Among authors: hwang yy. J Clin Virol. 2014 Apr;59(4):255-8. doi: 10.1016/j.jcv.2014.01.005. Epub 2014 Jan 18. J Clin Virol. 2014. PMID: 24507802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters